🇺🇸 FDA
Pipeline program

5 mg Tadalafil

14393

Phase 3 small_molecule completed

Quick answer

5 mg Tadalafil for Benign Prostate Hyperplasia is a Phase 3 program (small_molecule) at Eli Lilly and Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Eli Lilly and Company
Indication
Benign Prostate Hyperplasia
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials